MSTN and breast cancer: In consideration of this fact, we tested the anti-Mstn antibody in a 4T1-syngeneic and a MDA-xenograft BC metastases mouse model and clearly demonstrated that anti-Mstn treatment significantly rescued trabecular bone loss and decreased OC formation in both mouse models.